Pathophysiology of Inborn Immunodeficiencies

Launched by UNIVERSITY OF ZURICH · Jan 29, 2018

Keywords

ClinConnect Summary

This clinical trial is focused on understanding a group of diseases known as primary immune deficiencies (PID), which make people more susceptible to infections and can cause unusual inflammatory responses. Researchers aim to learn more about why these conditions occur by examining samples from participants, such as blood and urine. The goal is to gather information that could help develop better, more targeted treatments that are specific to the different types of PID, rather than using treatments that may not work as well or have unwanted side effects.

To participate in this study, you need to have a clinical diagnosis of a primary immunodeficiency. The trial is open to volunteers of all ages and genders who are otherwise healthy. Participants will be asked to provide samples for analysis, and this process will help contribute to a better understanding of these immune disorders. It’s important to note that individuals with certain conditions, like secondary immunodeficiency or those who refuse to participate, will not be eligible for this study. If you or a loved one has been diagnosed with PID and are interested in contributing to this important research, please consider joining this trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of an inborn error of immunity (primary immunodeficiency, PID)
• • Clinically healthy (non-age matched) volunteer
• Exclusion Criteria:
• • exclusion of an inborn error of immunity
• • secondary immunodeficiency
• • refusal to enter the study